期刊文献+

盐酸氨基葡萄糖治疗对膝关节半月板损伤患者康复效果的影响 被引量:3

下载PDF
导出
摘要 目的:探究盐酸氨基葡萄糖治疗对膝关节半月板损伤患者康复效果的影响。方法:以2015年1月~2016年12月为时间区间,选择60例膝关节半月板损伤患者,按照入院先后顺序分为参照组、研究组,各30例,分别予以双醋瑞因、盐酸氨基葡萄糖治疗,对比康复效果。结果:研究组VAS评分、Lysholm功能评分、不良反应发生率分别为(1.67±0.87)分、(86.53±8.74)分、3.33%(1/30),参照组分别为(4.89±1.01)分、(55.92±10.61)分、20.00%(6/30),研究组VAS评分、不良反应发生率明显低于参照组,而Lysholm功能评分明显高于参照组,差异明显,(P<0.05)。结论:予以膝关节半月板损伤盐酸氨基葡萄糖治疗,可缓解疼痛,改善膝关节功能,降低不良反应发生率,促进康复,临床应用价值高。
作者 赵亮亮
出处 《北方药学》 2018年第7期128-129,共2页 Journal of North Pharmacy
  • 相关文献

参考文献4

二级参考文献49

  • 1Brereton N, Permington B, Ekelund M, et al. A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model[J]. J Med Econ, 2014, 30:1-8.
  • 2Essex MN, Behar R, O'Connell MA, et al. Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis[J]. Int J Gen Med, 2014, 16, 7:227-235.
  • 3Su SC, Tanimoto K, Tanne Y, et al. Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress [J]. Osteoarthritis Cartilage, 2014, 22(6): 845-851.
  • 4Yoo WH, Yoo HG, Park SH, et al. Efficacy and safety of PG201 and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study [J]. Rheumatol Int, 2014, 16 [Epub ahead of print].
  • 5Kellner HL, Li C, Essex MN. Celecoxib, Diclofenac and Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial[J]. Open Rheumatol J, 2013, 13, 7:96-100.
  • 6Conaghan PG, Bijlsma JW, Kneer W, et al. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety [J]. Curr Med Res Opin, 2014, 30(4): 599-611.
  • 7Hirayama A, Tanahashi N, Daida H, et al. Assessing the cardiovascular risk between eelecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis[J]. Circ J, 2013, 78(1): 194-205.
  • 8Kwoh CK, Roemer FW, Hannon M J, et al. Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial[J]. Arthritis Rheumatol, 2014, 66(4): 930-939.
  • 9Su N, Yang X, Liu Y, et al. Evaluation of arthrocentesis with hyaluronic acid injection plus oral glucosamine hydrochloride for temporomandibular joint osteoarthritis in oral-health-related quality of life[J]. J Craniomaxillofac Surg, 2014, 42(6): 846-851.
  • 10Gonzalez EB. Review: Glucosamine (sulfate or hydroehloride) does not reduce pain in knee or hip osteoarthritis[J]. Ann Intern Med, 2013, 17, 159(12): JC8.

共引文献61

同被引文献46

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部